Prevalence and long-term effect of antiplatelet use in inflammatory bowel disease

被引:0
|
作者
Mantaka, A. [1 ]
Renieri, V. [1 ]
Koutroubakis, I. [1 ]
机构
[1] Univ Hosp Heraklion, Dept Gastroenterol, Iraklion, Greece
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P340
引用
收藏
页码:S249 / S250
页数:2
相关论文
共 50 条
  • [1] Incidentally Diagnosed Inflammatory Bowel Disease: Prevalence and Long-Term Outcomes
    Bronze, S. M. Tubal
    Shenoy, S.
    Agrawal, M.
    Colombel, J. F.
    Rodriguez-Lago, I
    Ungaro, R. C.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I802 - I802
  • [2] An update on the safety of long-term vedolizumab use in inflammatory bowel disease
    Honap, Sailish
    Netter, Patrick
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (09) : 767 - 776
  • [3] An update on the safety of long-term vedolizumab use in inflammatory bowel disease
    Honap, Sailish
    Netter, Patrick
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    EXPERT OPINION ON DRUG SAFETY, 2023,
  • [4] LONG-TERM SAFETY OF THE SEQUENTIAL USE OF BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE
    Moens, Annick
    Ballet, Vera
    Sabino, Joao
    Vermeire, Severine
    Ferrante, Marc
    GASTROENTEROLOGY, 2020, 158 (06) : S1257 - S1258
  • [5] Long-term outcome of immunomodulator use in pediatric patients with inflammatory bowel disease
    van Hoeve, Karen
    Hoffman, Ilse
    D'Hoore, Andre
    Ferrante, Marc
    Vermeire, Severine
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (02) : 164 - 172
  • [6] Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease
    Te, HS
    Schiano, TD
    Kuan, SF
    Hanauer, SB
    Conjeevaram, HS
    Baker, AL
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (11): : 3150 - 3156
  • [7] Long-term outcome of immunomodulators use in paediatric patients with inflammatory bowel disease
    van Hoeve, K.
    Hoffman, I.
    Ferrante, M.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S143 - S144
  • [8] Inflammatory bowel disease: long-term therapeutic challenges
    Ashton, James J.
    Green, Zachary
    Kolimarala, Vinod
    Beattie, R. Mark
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1049 - 1063
  • [9] Long-term safety of vedolizumab for inflammatory bowel disease
    Loftus, Edward V., Jr.
    Feagan, Brian G.
    Panaccione, Remo
    Colombel, Jean-Frederic
    Sandborn, William J.
    Sands, Bruce E.
    Danese, Silvio
    D'Haens, Geert
    Rubin, David T.
    Shafran, Ira
    Parfionovas, Andrejus
    Rogers, Raquel
    Lirio, Richard A.
    Vermeire, Severine
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) : 1353 - 1365
  • [10] Long-term outcomes of pediatric inflammatory bowel disease
    Nasiri, Soheila
    Kuenzig, Mary Ellen
    Benchimol, Eric I.
    SEMINARS IN PEDIATRIC SURGERY, 2017, 26 (06) : 398 - 404